Dayton Osteopathic Hospital

Dayton Osteopathic Hospital was paid $111.27M by Medicaid between Jan 2018 and Dec 2024, across 544 billing codes. Its largest line is 99283, emergency room visit (moderate) — 13% of everything it billed.

33Billing provider infoDAYTON OSTEOPATHIC HOSPITAL
DAYTON, OH 45405

33aNPI1053339507assigned 07/17/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$111.27M

24GClaims2,461,104

24DCodes billed544

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#8 of 101

Median peer was paid$22.32M

This provider vs. median5.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official KO, TIMOTHY controls 20+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	210,425	$7.53M
2019	200,290	$6.93M
2020	183,867	$8.92M
2021	223,247	$10.55M
2022	268,537	$12.34M
2023	810,383	$39.28M
2024incomplete	564,355	$25.72M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	13%	120,446	111,338	$14.20M
96361	Intravenous infusion, hydration; each additional hour	12%	43,194	33,452	$13.48M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	11%	88,967	81,513	$12.46M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	9.1%	105,481	85,470	$10.14M
J9271	Injection, pembrolizumab, 1 mg	8.4%	1,338	864	$9.31M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	5.2%	38,908	34,333	$5.76M
70450	Computed tomography, head or brain; without contrast material	3.2%	13,780	12,045	$3.62M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.2%	17,260	10,461	$2.50M
74177	Computed tomography, abdomen and pelvis; with contrast material	2.2%	10,580	9,135	$2.47M
74176	Computed tomography, abdomen and pelvis; without contrast material	1.8%	7,680	6,538	$1.99M
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	1.6%	22,582	7,745	$1.77M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.5%	11,734	5,877	$1.70M

532 more codes

96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	1.5%	7,287	$1.63M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	1.2%	6,117	$1.30M
99282	Emergency department visit for the evaluation and management, low to moderate severity	1.0%	10,192	$1.16M
G0378	Hospital observation service, per hour	<1%	14,834	$1.11M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	2,153	$884K
J9299	Injection, nivolumab, 1 mg	<1%	200	$882K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	6,120	$794K
58662		<1%	423	$742K
80048	Basic metabolic panel (calcium, ionized)	<1%	118,217	$734K
80053	Comprehensive metabolic panel	<1%	62,363	$699K
71275	Computed tomographic angiography, chest, with contrast material	<1%	2,444	$645K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	17,121	$622K
58661		<1%	267	$593K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	4,680	$592K
96415		<1%	2,316	$585K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	3,229	$550K
J1439	Injection, ferric carboxymaltose, 1 mg	<1%	827	$539K
47562		<1%	247	$498K
93356		<1%	1,956	$483K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	3,541	$478K
J0897	Injection, denosumab, 1 mg	<1%	448	$469K
59025	Fetal non-stress test	<1%	3,042	$465K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	26,255	$437K
76830	Ultrasound, transvaginal	<1%	3,590	$344K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	194,304	$330K
62323		<1%	878	$308K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	2,064	$306K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	<1%	464	$295K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	11,592	$261K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,578	$244K
87529		<1%	26,198	$241K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	17,935	$232K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	391	$230K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	467	$225K
71046	Radiologic examination, chest; 2 views	<1%	13,725	$220K
84443	Thyroid stimulating hormone (TSH)	<1%	17,974	$217K
36415	Collection of venous blood by venipuncture	<1%	94,161	$216K
77063	Screening digital breast tomosynthesis, bilateral	<1%	4,530	$215K
70496		<1%	875	$208K
84484		<1%	53,073	$195K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	789	$188K
70491		<1%	660	$184K
71250		<1%	2,103	$177K
Q0222	Injection, bebtelovimab, 175 mg	<1%	366	$174K
93970		<1%	1,209	$167K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	15,555	$164K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	772	$163K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,005	$157K
58563		<1%	188	$154K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	2,230	$153K
76536		<1%	1,356	$152K
76642		<1%	1,133	$147K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	430	$144K
93971		<1%	1,887	$140K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	718	$137K
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	<1%	1,124	$129K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	2,442	$129K
72131		<1%	2,208	$128K
80076		<1%	44,188	$121K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	15,551	$121K
12001		<1%	804	$121K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	15,424	$118K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	60,362	$117K
97162		<1%	2,707	$116K
J1756	Injection, iron sucrose, 1 mg	<1%	6,475	$112K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	718	$111K
71045	Radiologic examination, chest; single view	<1%	39,620	$107K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	608	$106K
10060		<1%	668	$106K
80061	Lipid panel	<1%	8,346	$105K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	11,455	$104K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	670	$96K
72141		<1%	569	$95K
72125	Computed tomography, cervical spine; without contrast material	<1%	5,285	$93K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	4,287	$93K
J0561	Injection, penicillin g benzathine, 100,000 units	<1%	377	$92K
73221		<1%	451	$92K
71271		<1%	560	$91K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	135	$90K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	539	$89K
72100		<1%	1,792	$86K
73630		<1%	3,861	$86K
95811		<1%	109	$86K
J9173	Injection, durvalumab, 10 mg	<1%	38	$83K
82728		<1%	8,540	$82K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	55,053	$80K
97161		<1%	1,769	$77K
M0222	Intravenous injection, bebtelovimab, includes injection and post administration monitoring	<1%	367	$75K
96416		<1%	829	$75K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	59,687	$74K
36430		<1%	698	$72K
74018		<1%	1,743	$72K
86850		<1%	3,497	$71K
82607		<1%	5,520	$71K
96367		<1%	4,604	$70K
12002		<1%	453	$68K
97165		<1%	1,151	$67K
Q5114	Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg	<1%	40	$67K
73030		<1%	3,226	$67K
73562		<1%	2,523	$66K
29581		<1%	527	$65K
74183		<1%	265	$65K
73700		<1%	613	$64K
83036	Hemoglobin; glycosylated (A1C)	<1%	6,711	$64K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	5,220	$63K
97530	Therapeutic activities, direct patient contact, each 15 minutes	<1%	2,444	$63K
76775		<1%	602	$62K
93017		<1%	692	$57K
86780		<1%	2,851	$57K
J3490	Unclassified drugs	<1%	12,088	$56K
84439		<1%	4,182	$54K
86900		<1%	4,178	$52K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	86	$52K
97166		<1%	1,162	$51K
74178		<1%	192	$51K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	181	$51K
72040		<1%	899	$51K
J1050	Injection, medroxyprogesterone acetate, 1 mg	<1%	641	$49K
83540		<1%	8,395	$48K
12011		<1%	326	$48K
87086	Culture, bacterial; quantitative colony count, urine	<1%	9,451	$48K
73130		<1%	3,080	$47K
93880		<1%	587	$45K
76870		<1%	513	$45K
88307		<1%	610	$44K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	3,033	$44K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	2,516	$43K
73610		<1%	2,729	$43K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	1,425	$43K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	319	$42K
90715		<1%	2,642	$41K
81001		<1%	62,109	$40K
72110		<1%	767	$40K
85027		<1%	9,501	$40K
70486		<1%	1,404	$38K
83550		<1%	8,144	$37K
76882		<1%	373	$37K
73502		<1%	1,752	$35K
76770		<1%	238	$33K
80069		<1%	4,502	$32K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	2,121	$32K
75635		<1%	132	$32K
96375	Therapeutic injection; each additional sequential IV push	<1%	49,031	$32K
Q5107	Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg	<1%	30	$32K
30520		<1%	22	$31K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	28,121	$31K
P9045	Infusion, albumin (human), 5%, 250 ml	<1%	193	$30K
36591		<1%	10,930	$29K
86803		<1%	1,208	$28K
93923		<1%	318	$27K
81025		<1%	37,968	$27K
72132		<1%	787	$27K
77080		<1%	445	$27K
72128		<1%	1,110	$27K
83605		<1%	6,939	$26K
87511		<1%	1,011	$26K
73110		<1%	1,679	$25K
83880		<1%	5,024	$25K
74174		<1%	176	$24K
94727		<1%	397	$24K
94060		<1%	176	$24K
87070		<1%	4,673	$23K
94729		<1%	411	$23K
44970		<1%	12	$23K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,062	$23K
87210		<1%	6,517	$23K
77066	Tomosynthesis, mammo	<1%	623	$22K
82746		<1%	4,816	$22K
97535	Self-care/home management training, each 15 minutes	<1%	971	$22K
85610		<1%	7,902	$22K
81220	CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants	<1%	224	$22K
96523		<1%	596	$22K
J0640	Injection, leucovorin calcium, per 50 mg	<1%	1,787	$21K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,515	$21K
87480		<1%	3,051	$20K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	698	$20K
73200		<1%	160	$20K
83735		<1%	11,804	$20K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	1,554	$20K
11045		<1%	59	$19K
97014		<1%	492	$19K
72072		<1%	457	$19K
84702		<1%	2,937	$19K
84153		<1%	1,335	$18K
J0500	Injection, dicyclomine hcl, up to 20 mg	<1%	1,292	$17K
73560		<1%	1,618	$17K
77065	Tomosynthesis, mammo	<1%	464	$17K
80074		<1%	1,069	$16K
97116		<1%	699	$16K
93922		<1%	254	$16K
96368		<1%	2,038	$16K
76801		<1%	253	$15K
73564		<1%	360	$15K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	1,044	$15K
83021		<1%	737	$14K
73080		<1%	951	$14K
64400		<1%	50	$14K
86140		<1%	1,541	$14K
72197		<1%	61	$14K
83690		<1%	36,973	$14K
83970		<1%	658	$14K
70498		<1%	857	$13K
86762		<1%	903	$13K
73620		<1%	261	$13K
93308		<1%	52	$13K
92610		<1%	491	$12K
97597		<1%	300	$12K
92523		<1%	317	$12K
73590		<1%	1,041	$12K
84403		<1%	729	$12K
87660		<1%	3,050	$12K
86901		<1%	4,180	$12K
96376		<1%	7,519	$12K
64721		<1%	27	$11K
87510		<1%	3,051	$11K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	3,071	$11K
97035		<1%	133	$11K
73140		<1%	714	$11K
87340		<1%	898	$11K
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	992	$11K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	69	$11K
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	626	$10K
80320		<1%	846	$10K
85007		<1%	4,216	$10K
86923		<1%	609	$10K
82947		<1%	982	$10K
72050		<1%	169	$10K
85378		<1%	6,060	$10K
87077		<1%	3,784	$9K
82043		<1%	1,205	$9K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	2,087	$8K
49083		<1%	19	$8K
86431		<1%	497	$8K
81003		<1%	15,202	$8K
86334		<1%	700	$8K
96402		<1%	778	$8K
84436		<1%	418	$8K
85651		<1%	3,678	$8K
84146		<1%	381	$7K
64447		<1%	37	$7K
94010		<1%	47	$7K
43235		<1%	13	$7K
84481		<1%	566	$7K
87522	Neg quan hep c or qual rna	<1%	223	$7K
92133		<1%	152	$7K
72129		<1%	684	$7K
92134		<1%	274	$7K
82550		<1%	2,226	$7K
83516		<1%	445	$7K
82575		<1%	923	$7K
82248		<1%	1,137	$6K
J9045	Injection, carboplatin, 50 mg	<1%	861	$6K
88341		<1%	117	$6K
82784		<1%	902	$6K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	133	$6K
84100		<1%	2,271	$6K
82533		<1%	435	$6K
93225		<1%	47	$6K
72070		<1%	101	$6K
77049		<1%	14	$6K
43249		<1%	32	$6K
78264		<1%	30	$5K
73090		<1%	781	$5K
87186		<1%	2,814	$5K
86039		<1%	220	$5K
82525		<1%	439	$5K
83001		<1%	289	$5K
97113		<1%	79	$5K
82950		<1%	389	$5K
92083		<1%	139	$5K
J2543	Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams)	<1%	1,851	$5K
86038		<1%	413	$5K
84112		<1%	88	$5K
71101		<1%	540	$5K
83521		<1%	782	$4K
01999		<1%	1,559	$4K
85014		<1%	810	$4K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	94	$4K
86592		<1%	378	$4K
29125		<1%	1,161	$4K
36600		<1%	3,061	$4K
87040		<1%	4,396	$4K
64488		<1%	27	$4K
J3489	Injection, zoledronic acid, 1 mg	<1%	350	$4K
85660		<1%	785	$4K
83527		<1%	163	$4K
83615		<1%	2,368	$4K
90686		<1%	215	$4K
73718		<1%	17	$4K
84425		<1%	396	$4K
84156		<1%	1,025	$4K
72158		<1%	24	$4K
36592		<1%	263	$4K
84165		<1%	752	$4K
70487		<1%	15	$4K
84402		<1%	187	$4K
73060		<1%	441	$4K
86141		<1%	954	$3K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	5,495	$3K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	59	$3K
86304		<1%	421	$3K
J1650	Injection, enoxaparin sodium, 10 mg	<1%	5,202	$3K
84550		<1%	651	$3K
84590		<1%	413	$3K
86300		<1%	904	$3K
73552		<1%	474	$3K
87154		<1%	20	$3K
93226		<1%	43	$3K
76881		<1%	32	$3K
86376		<1%	159	$3K
82105		<1%	232	$3K
J1953	Injection, levetiracetam, 10 mg	<1%	444	$3K
85018		<1%	1,069	$3K
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	9,037	$3K
80164		<1%	312	$3K
58300		<1%	44	$3K
86480		<1%	69	$2K
73600		<1%	103	$2K
84703		<1%	1,648	$2K
82378		<1%	1,182	$2K
86147		<1%	130	$2K
84630		<1%	296	$2K
73120		<1%	99	$2K
96401		<1%	214	$2K
J2800	Injection, methocarbamol, up to 10 ml	<1%	696	$2K
82803		<1%	2,680	$2K
30140		<1%	21	$2K
72080		<1%	46	$2K
73522		<1%	47	$2K
72170		<1%	275	$2K
84450		<1%	392	$2K
94660		<1%	58	$2K
87081		<1%	567	$2K
82140		<1%	797	$2K
87634		<1%	850	$2K
J1170	Injection, hydromorphone, up to 4 mg	<1%	5,827	$2K
72082		<1%	19	$2K
85730		<1%	2,894	$2K
87507		<1%	18	$2K
84145		<1%	2,505	$2K
86235		<1%	137	$2K
85045		<1%	1,423	$2K
84132		<1%	1,543	$2K
84460		<1%	409	$2K
J8501	Aprepitant, oral, 5 mg	<1%	165	$2K
82670		<1%	91	$2K
83002		<1%	120	$2K
87205		<1%	1,418	$2K
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	53,453	$2K
86308		<1%	427	$2K
72156		<1%	12	$2K
86703		<1%	134	$2K
86706		<1%	106	$2K
84480		<1%	105	$1K
86800		<1%	110	$1K
82330		<1%	752	$1K
97760		<1%	21	$1K
G0008	Administration of influenza virus vaccine	<1%	307	$1K
00840		<1%	1,075	$1K
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	2,044	$1K
96411		<1%	1,011	$1K
J2270	Injection, morphine sulfate, up to 10 mg	<1%	6,390	$1K
93925		<1%	12	$1K
82565		<1%	198	$1K
86003		<1%	51	$1K
97010		<1%	23	$1K
J9263	Injection, oxaliplatin, 0.5 mg	<1%	408	$1K
82040		<1%	181	$1K
74246		<1%	12	$1K
82977		<1%	269	$1K
86255		<1%	52	$1K
86200		<1%	64	$1K
82570		<1%	143	$1K
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	7,956	$1K
J1644	Injection, heparin sodium, per 1000 units	<1%	7,139	$1K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	5,903	$1K
82247		<1%	215	$1K
83010		<1%	286	$1K
J7999	Compounded drug, not otherwise classified	<1%	596	$1K
83721		<1%	90	$1K
J9171	Injection, docetaxel, 1 mg	<1%	22	$1K
J9060	Injection, cisplatin, powder or solution, 10 mg	<1%	77	$924.57
73501		<1%	56	$887.09
86225		<1%	76	$859.62
88342		<1%	2,216	$858.07
97163		<1%	12	$847.54
85576		<1%	33	$812.23
72220		<1%	13	$798.11
29130		<1%	205	$786.51
73660		<1%	57	$754.24
71100		<1%	12	$742.81
01400		<1%	146	$734.76
82150		<1%	221	$722.48
73070		<1%	65	$681.58
96377		<1%	464	$671.68
73100		<1%	40	$653.82
76819	Fetal biophysical profile; without non-stress testing	<1%	19	$614.56
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	16,215	$581.58
J3475	Injection, magnesium sulfate, per 500 mg	<1%	3,109	$569.53
72120		<1%	14	$567.35
87486		<1%	19	$557.84
J2550	Injection, promethazine hcl, up to 50 mg	<1%	3,530	$553.32
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	37,327	$550.39
87324		<1%	83	$540.02
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	937	$535.46
99195		<1%	30	$488.26
J3473	Injection, hyaluronidase, recombinant, 1 usp unit	<1%	17	$475.62
72052		<1%	13	$434.16
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	17,005	$410.93
85049		<1%	450	$410.68
J2360	Injection, orphenadrine citrate, up to 60 mg	<1%	993	$401.68
82010		<1%	1,229	$399.70
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	1,885	$385.73
80177		<1%	28	$374.90
87449		<1%	72	$369.35
00731		<1%	515	$362.21
J0360	Injection, hydralazine hcl, up to 20 mg	<1%	883	$356.94
86146		<1%	58	$349.24
83655		<1%	12	$340.70
87075		<1%	639	$323.72
87581		<1%	19	$317.39
J3370	Injection, vancomycin hcl, 500 mg	<1%	1,466	$315.19
90656		<1%	48	$294.17
J0171	Injection, adrenalin, epinephrine, 0.1 mg	<1%	814	$291.62
90662		<1%	87	$287.06
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	618	$286.00
C1769	Guide wire	<1%	822	$285.00
J0780	Injection, prochlorperazine, up to 10 mg	<1%	1,452	$264.06
J3411	Injection, thiamine hcl, 100 mg	<1%	1,079	$260.72
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	<1%	290	$256.89
J1380	Injection, estradiol valerate, up to 10 mg	<1%	15	$245.49
J2704	Injection, propofol, 10 mg	<1%	4,591	$233.31
88304		<1%	1,378	$204.99
J1805	Injection, esmolol hydrochloride, 10 mg	<1%	332	$190.37
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	1,847	$189.35
86704		<1%	27	$185.32
86301		<1%	32	$167.14
81015		<1%	137	$165.03
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	<1%	1,028	$143.97
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	11,761	$140.00
82024		<1%	16	$129.60
J1940	Injection, furosemide, up to 20 mg	<1%	1,419	$128.58
J1790	Injection, droperidol, up to 5 mg	<1%	1,723	$128.11
J0690	Injection, cefazolin sodium, 500 mg	<1%	2,974	$125.25
J0737	Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg	<1%	240	$119.63
C1887	Catheter, guiding (may include infusion/perfusion capability)	<1%	365	$117.00
J2060	Injection, lorazepam, 2 mg	<1%	1,650	$109.92
29515		<1%	29	$102.95
84155		<1%	47	$95.31
84075		<1%	34	$94.41
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	286	$93.37
J3480	Injection, potassium chloride, per 2 meq	<1%	2,241	$93.22
J9190	Injection, fluorouracil, 500 mg	<1%	1,617	$92.22
J2471	Injection, pantoprazole (hikma), not therapeutically equivalent to j2470, 40 mg	<1%	187	$87.86
J3360	Injection, diazepam, up to 5 mg	<1%	393	$80.87
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	144	$78.65
94667		<1%	14	$76.04
J9267	Injection, paclitaxel, 1 mg	<1%	873	$75.13
J2795	Injection, ropivacaine hydrochloride, 1 mg	<1%	2,296	$68.06
G1004	Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program	<1%	279	$67.62
88302		<1%	439	$66.10
85520		<1%	92	$62.68
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	1,446	$55.85
J0613	Injection, calcium gluconate (wg critical care), not therapeutically equivalent to j0612, 10 mg	<1%	88	$47.61
J1020	Injection, methylprednisolone acetate, 20 mg	<1%	137	$46.96
J1626	Injection, granisetron hydrochloride, 100 mcg	<1%	598	$44.19
J1010	Injection, methylprednisolone acetate, 1 mg	<1%	248	$40.15
96417		<1%	2,096	$39.48
99152		<1%	231	$37.75
J2370	Injection, phenylephrine hcl, up to 1 ml	<1%	718	$36.00
J1630	Injection, haloperidol, up to 5 mg	<1%	487	$36.00
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	1,557	$28.69
85347		<1%	140	$28.56
84295		<1%	201	$27.04
J0689	Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg	<1%	1,276	$27.03
J0592	Injection, buprenorphine hydrochloride, 0.1 mg	<1%	404	$25.87
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	453	$22.53
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	<1%	201	$22.47
82375		<1%	69	$21.87
87147		<1%	12	$18.56
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	327	$17.74
82810		<1%	53	$15.59
J3410	Injection, hydroxyzine hcl, up to 25 mg	<1%	81	$13.90
J8540	Dexamethasone, oral, 0.25 mg	<1%	22	$13.21
83050		<1%	69	$11.51
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	<1%	1,932	$10.55
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	278	$9.51
Q0177	Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	1,066	$9.49
J1171	Injection, hydromorphone, 0.1 mg	<1%	417	$7.68
J0456	Injection, azithromycin, 500 mg	<1%	298	$6.89
94761		<1%	1,187	$6.22
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	867	$4.84
J2470	Injection, pantoprazole sodium, 40 mg	<1%	80	$2.46
J2305	Injection, nitroglycerin, 5 mg	<1%	12	$1.49
88311		<1%	515	$1.25
J0461	Injection, atropine sulfate, 0.01 mg	<1%	162	$0.76
C1776	Joint device (implantable)	0%	321	$0.00
01810		0%	199	$0.00
C1729	Catheter, drainage	0%	172	$0.00
C1751	Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis)	0%	157	$0.00
92015	Determination of refractive state	0%	144	$0.00
15853		0%	81	$0.00
00300		0%	255	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	136	$0.00
00940		0%	15	$0.00
00811		0%	318	$0.00
C1760	Closure device, vascular (implantable/insertable)	0%	43	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	31	$0.00
01830		0%	193	$0.00
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate)	0%	47	$0.00
C1780	Lens, intraocular (new technology)	0%	28	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	35	$0.00
51702		0%	45	$0.00
A9537	Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries	0%	17	$0.00
J0295	Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm	0%	113	$0.00
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	0%	21	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	433	$0.00
C1889	Implantable/insertable device, not otherwise classified	0%	508	$0.00
00813		0%	359	$0.00
C1781	Mesh (implantable)	0%	123	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	240	$0.00
00160		0%	41	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	93	$0.00
00790		0%	257	$0.00
94760		0%	375	$0.00
00952		0%	243	$0.00
J0610	Injection, calcium gluconate (fresenius kabi), per 10 ml	0%	49	$0.00
76377		0%	41	$0.00
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	0%	17	$0.00
J1836	Injection, metronidazole, 10 mg	0%	73	$0.00
01480		0%	13	$0.00
C9290	Injection, bupivacaine liposome, 1 mg	0%	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialKO, TIMOTHY (KETTERING HEALTH CFO)

Same official

Other billing entities under KO, TIMOTHY

Full network →

Provider	Location	Paid
Alliance Physicians INC	Kettering, OH	$38.76M
Kettering Medical Center	Kettering, OH	$37.96M
Beavercreek Medical Center	Beavercreek, OH	$30.49M
The Fort Hamilton Hospital	Hamilton, OH	$27.06M
Kettering Medical Center	Miamisburg, OH	$20.00M
Greene Memorial Hospital INC	Xenia, OH	$11.31M
Kettering Medical Center	Troy, OH	$10.83M
Kettering Independent Medical Group INC	Miamisburg, OH	$8.39M
Kettering Affiliated Health Services	Miamisburg, OH	$2.12M
Greene Memorial Hospital, INC.	Jamestown, OH	$1.53M
Alliance Physicians INC	Moraine, OH	$1.42M
Alliance Physicians INC	Huber Heights, OH	$1.06M
Greene Memorial Hospital INC	Yellow Springs, OH	$843K
Alliance Physicians INC	Miamisburg, OH	$744K
Greene Memorial Hospital INC	Cedarville, OH	$703K
Alliance Physicians INC	Xenia, OH	$645K
Alliance Physicians INC	Springboro, OH	$616K
Alliance Physicians INC	Kettering, OH	$599K
Sycamore Primary Care Group	Miamisburg, OH	$564K
Alliance Physicians INC	Beavercreek, OH	$486K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.